38 filings
8-K
NEXI
Neximmune Inc
5 Apr 24
Departure of Directors or Certain Officers
4:06pm
8-K
NEXI
Neximmune Inc
5 Feb 24
NexImmune Announces $3.67 Million
5:10pm
8-K
NEXI
Neximmune Inc
2 Feb 24
Termination of a Material Definitive Agreement
1:25pm
8-K
NEXI
Neximmune Inc
1 Feb 24
Other Events
9:17am
8-K
NEXI
Neximmune Inc
19 Jan 24
Submission of Matters to a Vote of Security Holders
4:43pm
8-K
dy3gjx2
22 Dec 23
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
p81te6h
1 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1:39pm
8-K/A
wmsl95ieyf kgec
20 Nov 23
Cost Associated with Exit or Disposal Activities
5:01pm
8-K
h7kjuh
2 Nov 23
Cost Associated with Exit or Disposal Activities
5:12pm
8-K
326oza8pls2b
2 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:33pm
8-K
6sppr
18 Oct 23
NexImmune Announces 1-for-25 Reverse Stock Split
4:15pm
8-K
e66hwks zail7rf
15 Sep 23
Departure of Directors or Certain Officers
4:06pm
8-K
2kkatkch qnga1j
31 Aug 23
Cost Associated with Exit or Disposal Activities
5:11pm
8-K
45m5ta
10 Aug 23
NexImmune Reports Second Quarter 2023 Financial Results and Provides Business Updates
4:06pm
8-K
26nknmb kwsctt47j8
5 Jun 23
NexImmune Presents Initial Positive Data in the NEXI-001 Phase 1 Trial for Relapsed/Refractory Post
8:37am
8-K
vbrq33 793
18 May 23
Submission of Matters to a Vote of Security Holders
4:11pm
8-K
nm4yxz28xe mr9
15 May 23
NexImmune Reports First Quarter 2023 Financial Results and Provides Business Updates
4:03pm
8-K
bf8mtwyzlnfjmdb jm
26 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:16pm
8-K
rtvljy0jkobswhsme
28 Mar 23
NexImmune Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
4:07pm
8-K
48zh7v6sp fugh5i
10 Mar 23
Regulation FD Disclosure
5:07pm